SCHEMBL29469680

SCHEMBL29469680

CCOc1cc(F)ccc1S(=O)(=O)NC(=O)c1cc2c(F)cc(N3CCC3)cc2o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.40
LMNA P02545 4/20 0.37
MAPT P10636 2/20 0.37
KAT6A Q92794 1/20 0.36
KCNH2 Q12809 7/20 0.35
HSD17B10 Q99714 3/20 0.34
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MCHR1 Q99705 7/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HTT P42858 1/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24334319 1.00 TP53 (0.40) TP53LMNAMAPTKAT6AKCNH2
SCHEMBL24334334 0.93 LMNA (0.41) TP53LMNAMAPTKAT6AKCNH2
SCHEMBL29469617 0.93 LMNA (0.41) TP53LMNAMAPTKAT6AKCNH2
SCHEMBL24333954 0.92 TP53 (0.42) TP53LMNAMAPTKAT6AKCNH2
SCHEMBL24333735 0.91 TP53 (0.36) TP53LMNAMAPTKAT6AHSD17B10
SCHEMBL29469701 0.87 TSHR (0.43) TP53LMNAMAPTKAT6AHSD17B10
SCHEMBL24333640 0.87 TSHR (0.43) TP53LMNAMAPTKAT6AHSD17B10
SCHEMBL24334414 0.87 LMNA (0.48) LMNAMAPTKAT6AALDH1A1NPSR1
SCHEMBL24333774 0.86 ALDH1A1 (0.44) TP53LMNAMAPTHSD17B10ALDH1A1
SCHEMBL24334244 0.86 LMNA (0.37) TP53LMNAMAPTKAT6AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed